AARDVARK THERAPEUTICS, INC.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
- First Posted Date
- 2025-02-17
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Aardvark Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT06828861
- Locations
- ๐บ๐ธ
Children's of Alabama, Birmingham, Alabama, United States
๐บ๐ธRady Children's Hospital, Encinitas, California, United States
๐บ๐ธStanford Childrens Health Specialty Services, Palo Alto, California, United States
A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
Phase 2
Completed
- Conditions
- Autism Spectrum Disorder
- Interventions
- Drug: High Dose ARD-501Drug: PlaceboDrug: Low Dose ARD-501
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Aardvark Therapeutics, Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT06126653
- Locations
- ๐บ๐ธ
Center for Psychiatry and Behavioral Medicine Inc, Las Vegas, Nevada, United States
Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
- First Posted Date
- 2022-01-31
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- Aardvark Therapeutics, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05215847
- Locations
- ๐บ๐ธ
Altman Clinical and Translational Research Institute, University of California, San Diego, San Diego, California, United States
A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2025-05-09
- Lead Sponsor
- Aardvark Therapeutics, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT05153434
- Locations
- ๐บ๐ธ
Stanford University, Palo Alto, California, United States
๐บ๐ธChildren's Hospital Colorado, Aurora, Colorado, United States
Study to Evaluate ARD-101 in Adults With Obesity
- First Posted Date
- 2021-11-16
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Aardvark Therapeutics, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT05121441
- Locations
- ๐บ๐ธ
Altman Clinical and Translational Research Institute, University of California, San Diego, San Diego, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath